These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 24099552

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Determination of flow properties of pharmaceutical powders by near infrared spectroscopy.
    Sarraguça MC, Cruz AV, Soares SO, Amaral HR, Costa PC, Lopes JA.
    J Pharm Biomed Anal; 2010 Aug 01; 52(4):484-92. PubMed ID: 20167448
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Excipient-Induced Lattice Disorder in Active Pharmaceutical Ingredient: Implications on Drug Product Continuous Manufacturing.
    Munjal B, DeBoyace K, Cao F, Krzyzaniak JF, Arora KK, Suryanarayanan R.
    Mol Pharm; 2024 Oct 07; 21(10):5150-5158. PubMed ID: 39137015
    [Abstract] [Full Text] [Related]

  • 50. Flow rate and flow equation of pharmaceutical free-flowable powder excipients.
    Sklubalová Z, Zatloukal Z.
    Pharm Dev Technol; 2013 Feb 07; 18(1):106-11. PubMed ID: 22149908
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP, Elliott JA, Cameron RE.
    Eur J Pharm Sci; 2010 Jul 11; 40(4):352-8. PubMed ID: 20417708
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I, Bodmeier R.
    Eur J Pharm Biopharm; 2010 May 21; 75(1):63-70. PubMed ID: 20079833
    [Abstract] [Full Text] [Related]

  • 59. Characteristics of pharmaceutical grade phyllosilicate powders.
    Viseras C, López-Galindo A.
    Pharm Dev Technol; 2000 May 21; 5(1):47-52. PubMed ID: 10669917
    [Abstract] [Full Text] [Related]

  • 60. [Characterization of flowability of pharmaceutical powders based on multivariate analysis method].
    Du Y, Zhao LJ, Xiong YK, Li XH, Wang ST, Feng Y, Xu DS.
    Yao Xue Xue Bao; 2012 Sep 21; 47(9):1231-6. PubMed ID: 23227556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.